DOSAGE DEPENDENT BIOAVAILABILITY OF DIGOXIN

被引：0
|
作者：
OCHS, HR [1 ]
BODEM, G [1 ]
机构：
[1] UNIV BONN, MED KLIN, D-5300 BONN 1, FED REP GER
来源：
ZEITSCHRIFT FUR KARDIOLOGIE | 1980年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [41] INTRAVENOUS DIGOXIN AS A BIOAVAILABILITY STANDARD
    STOLL, RG
    WAGNER, JG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1975, 17 (01) : 117 - 118
  • [42] BIOAVAILABILITY OF DIGOXIN IN FIXED COMBINATIONS
    OCHS, H
    BODEM, G
    DENGLER, HJ
    KLINISCHE WOCHENSCHRIFT, 1974, 52 (13): : 637 - 639
  • [43] BIOAVAILABILITY OF NEW DIGOXIN (ZORI)
    DANON, A
    BENZVI, Z
    KAPLANSKI, J
    CHEN, Z
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1977, 13 (03): : 331 - 331
  • [44] PHARMACOKINETICS OF DIGOXIN - INTERPRETING BIOAVAILABILITY
    SANCHEZ, N
    SHEINER, LB
    HALKIN, H
    MELMON, KL
    BRITISH MEDICAL JOURNAL, 1973, 4 (5885): : 132 - 134
  • [45] BIOAVAILABILITY OF DRUGS - FOCUS ON DIGOXIN
    LEVY, G
    GIBALDI, M
    CIRCULATION, 1974, 49 (03) : 391 - 394
  • [46] ABSOLUTE BIOAVAILABILITY OF DIGOXIN TABLETS
    BEVERIDGE, T
    NUESCH, E
    OHNHAUS, EE
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1978, 28-1 (04): : 701 - 703
  • [47] DIGOXIN BIOAVAILABILITY AND HYPOCHOLESTEROLEMIC INTERVENTIONS
    BROWN, DD
    JUHL, RP
    CLINICAL RESEARCH, 1977, 25 (04): : A552 - A552
  • [48] EFFECT OF QUINIDINE ON DIGOXIN BIOAVAILABILITY
    HAGER, WD
    MAYERSOHN, M
    GRAVES, P
    CLINICAL RESEARCH, 1981, 29 (01): : A22 - A22
  • [49] DIGOXIN AND APHA BIOAVAILABILITY PROJECT
    COLAIZZI, JL
    JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1973, NS13 (11): : 603 - 603
  • [50] DIGOXIN MAINTENANCE DOSAGE IN OBESITY
    GRAUER, K
    ROBINSON, JD
    AMERICAN HEART JOURNAL, 1982, 104 (02) : 320 - 320
12345